Flora Growth Corp. acquires Dr. Annabelle Manalo-Morgan's brand Masaya

219
3
Flora Growth Corp. acquires Dr. Annabelle Manalo-Morgan's brand Masaya

Flora Growth Corp. FLGC entered an agreement with a cell biologist, Dr. Annabelle Manalo-Morgan, Ph. With its patent-pending CBD formulations, D. was able to acquire her brand Masaya. Masaya s formulations of pure, potent CBD oil are 100% THC-free and have a long track record of positive testimonials collected over years of use, and are backed by her research. Flora plans to distribute the brand and its formulations worldwide.

Masaya will be the first offering from Flora Life Sciences in the US and will be the first owned Flora brand sold in the US. In addition, it is expected that the original patent-pending formulation, Masaya Pure, will be used in Flora's current clinical trials with the University of Manchester in the UK. One of the first distribution steps beyond the US is currently being registered with the Colombian regulatory agency, INVIMA.

We are excited to announce the acquisition of Masaya. The formulation of the brand was developed by Dr. Annabelle for his son and has been used by thousands of consumers. Flora s chairman and CEO Luis Merchan stated that the aim of the mission is to be enriched by Dr. Annabelle and her son's beautiful story and to improve the well-being of people around the world. This acquisition allows us to deliver on our promise to invest in safe, thorough, cutting-edge scientific research that can bring meaningful change through an affordable and effective product offering for people worldwide. As a member of Flora's board of directors and as the company's scientific advisor, Dr. Annabelle is responsible for Flora's global research initiatives, including Flora's ongoing clinical trial on the use of cannabinoids with patients who have fibromyalgia in partnership with the University of Manchester in the UK. Those clinical trials are expected to expand into research about the use of cannabinoids for other medical indications in the UK, at Flora's research facilities in Colombia and in the US. The proceeds from the sale of Masaya products are expected to contribute to the funding of this vital research.

After the birth of her son Macario in 2016, Annabelle watched him suffer from as many as 200 seizures per day, which led doctors to remove 38 percent of his brain. Dr. Annabelle tried to find alternative solutions for Macario, and eventually discovered CBD, which has helped Macario, now six, become a happy and thriving child.

After my experience with my son Macario, I am very excited to bring Masaya to more consumers around the world, and I am very excited to do my very best to help as many people as possible," said Dr. Annabelle, lead scientific advisor and director of Flora. Both consumers and the global scientific community deserve more research and data about the science behind CBD, and I feel very grateful to be working with the Flora team to develop some of the highest-quality, scientifically vetted products in the world. Annabelle is a scientist, educator, author, mother of five, and a respected key opinion leader. She is a cell and developmental biologist with a doctorate from Vanderbilt University in Nashville, Tennessee, with a background in neuroscience from Georgetown University. She earned her Ph. D. in cell and developmental biology with a focus in cardio-oncology, has since become a philanthropist and entrepreneur focused on pharmaceutical innovation and clinical trial research in medical cannabis.